Claire Stawnyczy, CEO of Lophos Pharmaceuticals MESC, was a guest recently on Benzinga’s All-Access.
Lophos Pharmaceuticals is a bioscience company involved in the research and development of mescaline and peyote medicines for indications from mental health to alcohol use disorder. The company is also the largest producer of peyote in Canada, having developed a process that shrinks the cultivation time from 13 years in the wild to 3 years.
Lophos just received their CSDL from Health Canada.
Learn more here:
Featured photo by Christopher Cassidy on Unsplash.
This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.